Search Results - "Monserrat, L."

Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles by Fafián-Labora, J., Lesende-Rodriguez, I., Fernández-Pernas, P., Sangiao-Alvarellos, S., Monserrat, L., Arntz, O. J., van de Loo, F. A. J., Mateos, J., Arufe, M. C.

“…Stem cells possess significant age-dependent differences in their immune-response profile. These differences were analysed by Next-Generation Sequencing of six…”
Get full text

Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases by Elliott, Perry, Andersson, Bert, Arbustini, Eloisa, Bilinska, Zofia, Cecchi, Franco, Charron, Philippe, Dubourg, Olivier, Kühl, Uwe, Maisch, Bernhard, McKenna, William J., Monserrat, Lorenzo, Pankuweit, Sabine, Rapezzi, Claudio, Seferovic, Petar, Tavazzi, Luigi, Keren, Andre

“…In biology, classification systems are used to promote understanding and systematic discussion through the use of logical groups and hierarchies. In clinical…”
Get full text

Factors of Poor Prognosis Associated with Chronic Kidney Disease by Stage in Ambulatory Patients: A Cross-sectional Study by Valdez Ortiz, Rafael, Escorza-Valdivia, Samantha, Benitez-Renteria, Sigfrido, Lopez-Alvarenga, Juan Carlos, Pérez-Navarro, L. Monserrat

“…BACKGROUNDMexico has a high prevalence of chronic kidney disease (CKD) but limited information about the early stages of CKD and their clusters of poor…”
Get full text

Familial evaluation reveals a distinct genetic cause in a large Spanish family with neurofibromatosis 1 and hypertrophic cardiomyopathy by Salazar-Mendiguchía, J., Díez-López, C., Claver, E., Cesar, S., Campuzano, O., Sarquella-Brugada, G., Monserrat, L.

“…•Classically, it has been described that HCM is a cardiovascular manifestation of NF1.•We report a large family with pathogenic variants in NF1 and in…”
Get full text

A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD) by O'Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J. R., Limongelli, G., McKenna, W. J., Omar, R. Z., Elliott, P. M.

Get full text

Cardiac challenges in patients with Fabry disease by Weidemann, F, Linhart, A, Monserrat, L, Strotmann, J

“…Abstract Fabry disease, an X-linked lysosomal storage disorder affecting both men and women, is a relatively prevalent cause of hypertrophic cardiomyopathy…”
Get full text

A mutation in the Z-line Cypher/ZASP protein is associated with arrhythmogenic right ventricular cardiomyopathy by Lopez-Ayala, J. M., Ortiz-Genga, M., Gomez-Milanes, I., Lopez-Cuenca, D., Ruiz-Espejo, F., Sanchez-Munoz, J. J., Oliva-Sandoval, M. J., Monserrat, L., Gimeno, J. R.

“…Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an important cause of malignant arrhythmia and sudden death particularly in young people. Although it…”
Get full text

Corrigendum: Effect of age on pro-inflammatory miRNAs contained in mesenchymal stem cell-derived extracellular vesicles by Fafián-Labora, J, Lesende-Rodriguez, I, Fernández-Pernas, P, Sangiao-Alvarellos, S, Monserrat, L, Arntz, O J, van de Loo, F A J, Mateos, J, Arufe, M C

“…This corrects the article DOI: 10.1038/srep43923…”
Get full text

THE REVOLUTION, WE HAVE ALMOST OVERSLEPT by Zateyshchikov, D. A., Monserrat, L.

“…Human genome decoding and the development of relatively simple methods of sequencing made it possible to unveil genetic origin of various diseases, including…”
Get full text

Computerized registry of patients with hemorrhagic hereditary telangiectasia (RiHHTa Registry) in Spain: Objectives, methods, and preliminary results by Riera-Mestre, A, Mora Luján, J M, Sanchez Martínez, R, Torralba Cabeza, M A, Patier de la Peña, J L, Juyol Rodrigo, M C, Lopez Wolf, D, Ojeda Sosa, A, Monserrat, L, López Rodríguez, M

“…INTRODUCTIONHereditary hemorrhagic telangiectasia (HHT) is a rare disease with autosomal dominant inheritance that causes systemic vascular affectation…”
Get full text

Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease by Monserrat, L, Barriales-Villa, R, Hermida-Prieto, M

Get more information

PULSE REDUCTION IN MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY (TWO CLINICAL CASES) by Krylova, N. S., Kovalevskaya, E. A., Poteshkina, N. G., Mershina, Е. A., Sinitsyn, V. Е., Sonicheva, N. A., Monserrat, L.

“…Two clinical cases presented, of the patients with hypertrophic cardiomyopathy and individualized pulse reduction therapy approach. Patients were prescribed…”
Get full text

Effects of weaning and finishing feeding treatment on fatty acids, especially cis and trans C18:1 isomers, in the Longissimus thoracis muscle of Galician Blond calves by Bispo, E, Moreno, T, Thomas, A, Durand, D, Monserrat, L, Gonzalez, L, Bauchart, D

“…Seven- to 10-month-old calves are the typical production of Galician Blond (GB), the most important bovine local beef breed in Spain. As meat lipid…”
Get full text

Effect of weaning status and storage time under vacuum upon physical characteristics of meat of the Rubia Gallega breed by Oliete, B., Carballo, J.A., Varela, A., Moreno, T., Monserrat, L., Sánchez, L.

“…Seven to nine months old calves are the typical production of Rubia Gallega, which is the most important beef breed in Spain. A study about the influence of…”
Get full text

Development of knowledge-based clinical decision support system for the management of cardiovascular diseases by L Canoa, J, Pena Gil, C, Monserrat, L

“…Abstract Background Knowledge-based clinical decision support systems (CDSS) are technological tools that analyze patient information and present justified…”
Get full text

Influence of ageing time on the quality of yearling calf meat under vacuum by Oliete, B, Moreno, T, Carballo, J.A, Varela, A, Monserrat, L, Sanchez, L

“…The objective of this study is to determine the effect of the ageing time on the quality characteristics of yearling calf meat under vacuum. Ninety-six Rubia…”
Get full text

Prevalence of fabry disease in a cohortof 479 unrelated patients with hypertrophic cardiomyopathy by Monserrat, L, Gimeno-Blanes, J.R, Marin-Ortuño, F, González-Cabrero, J, Hermida-Prieto, M, Garcia-Honrubia, A, Perez, I, Fernández, X, de la Morena, G, Paya, E, Yagüe, J, Egido, J

Get full text

79 (PB067): Identification of biomarkers of response and the mechanism of action of a selective androgen receptor modulator in estrogen receptorpositive breast cancer patient-derived xenografts by Monserrat, L., García, J. García, Gutiérrez, C. Molina, Viaplana, C., Brasó-Maristany, F., Bellet, M., Chandarlapaty, S., Nonell, L., Ponomarenko, J., Canals, F., Vicent, G. Pablo, Serra, V.

Get full text

Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases by Charron, Philippe, Arad, Michael, Arbustini, Eloisa, Basso, Cristina, Bilinska, Zofia, Elliott, Perry, Helio, Tiina, Keren, Andre, McKenna, William J., Monserrat, Lorenzo, Pankuweit, Sabine, Perrot, Andreas, Rapezzi, Claudio, Ristic, Arsen, Seggewiss, Hubert, van Langen, Irene, Tavazzi, Luigi

“…Advances in molecular genetics present new opportunities and challenges for cardiologists who manage patients and families with cardiomyopathies. The aims of…”
Get full text

Development of knowledge-based clinical decision support system for the management of cardiovascular diseases by L Canoa, J, Pena Gil, C, Monserrat, L

“…Abstract Background Knowledge-based clinical decision support systems (CDSS) are technological tools that analyze patient information and present justified…”
Get full text